Poster Session F - Molecular Medicine 3.
Dr. Toth, Daniel
uwfgef
Department of Biophysics and Radiation Biology
+36706033515
toth.daniel@phd.semmelweis.hu
Delving Deep: Enhanced Insights from Molecular Dynamic Simulations of Complexed SULT1A1 Dimers
Daniel Toth1,2, Balint Dudas3, Maria A. Miteva2, Erika Balog1
1: Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary
2: Inserm U1268 MCTR, CiTCoM UMR 8038 CNRS - Université Paris Cité, Pharmacy Faculty of Paris, France
3: Department of Physics and Astronomy, University College London, London WC1E 6BT, United Kingdom
Poszter
Poster Session F - Molecular Medicine 3.
English
Molecular Medicine
Our project aims to elucidate the diverse mechanisms guiding the selectivity of Sulfotransferase enzymes (SULTs). These phase II metabolizing enzymes catalyze sulfate transfers from their co-factor 3′-Phosphoadenosine 5′-Phosphosulfate (PAPS) to various substrates, thereby facilitating the elimination of diverse molecules such as drugs, hormones, and neurotransmitters. In our previous studies we have explored key differences of the SULT isoforms, however a deeper clarification of the basic mechanisms of these enzymes are still an ongoing effort in the field.
We strongly suspect that dimerization, a well-known attribute of these enzymes are playing a key role in unraveling these mechanisms, which was inadequately explored in previous studies.
For this end, we use multiple in silico methods, like molecular dynamics (MD) simulations, molecular docking and force distribution analysis (FDA), specifically focusing on dimer systems. By including the cofactor PAPS and a known large substrate, fulvestrant, we could explore an extended range of the conformational space of SULT1A1 dimers, shedding new light on the structural dynamics of the systems under study.
These results can be helpful in the future to develop an algorithm for machine learning, that could differentiate and even predict new substrates, thus helping in the development of ADME-Tox profiling of novel drug candidates and xenobiotics.
This project was funded by the Ministry for Innovation and Technology in Hungary (TKP2021 EGA 23), Ministére francais de l’Europe et des Affaires Etrangéres (2021-0143339), and Tét-Balaton project „drug-drug interactions of sulfotransferases” ( 2019-2.1.11-TÉT-2020-00096 ).
Semmelweis University
Université Paris Cité, Pharmacy Faculty of Paris, France
Dr. Erika Balog, Dr. Maria Miteva
I give consent to the publication of my abstract on the website of the congress.
Szabad
elfogadva
poszter
nem rendelkezett róla
6110
14:45
14:48